Journal article icon

Journal article

Acceptability and feasibility of biomarkers of airway eosinophilic inflammation for the management of preschool wheeze: a qualitative study

Abstract:
Objective: This study aimed to examine whether biomarker tests—finger-prick, skin-prick and offline fractional exhaled nitric oxide (FeNO)—are acceptable and feasible as a guide to treatment decisions, uniquely combining the perspectives of parents of preschool children with wheeze and healthcare professionals (HCPs) working in National Health Service (NHS) primary care. Design: Qualitative interview study. Criterion sampling was used to recruit 16 parents from 16 families, and convenience sampling to recruit 16 HCPs (doctors and nurses) from 14 primary care NHS practices. Qualitative data were collected via online one-to-one interviews and focus groups (FGs), conducted on Microsoft Teams, transcribed and thematically analysed within the NVivo software package. Results: Parents described the biomarker tests as acceptable when they were supported by evidence of effectiveness and empathetic communication from HCPs. Skin-prick testing was the most preferred test by parents as it helped them minimise allergen exposures. HCPs favoured finger-prick and FeNO tidal breathing test due to greater familiarity and feasibility in primary care. Time constraints, cost of devices and training to perform the biomarker tests were reported as barriers to implementation. Both groups agreed that testing frequency should depend on wheeze severity. Finally, a proposed future randomised controlled trial examining whether a biomarker-based approach is superior to the current symptom-based approach was regarded as acceptable and feasible. Conclusion: Finger-prick, skin-prick and FeNO testing are conditionally acceptable and feasible in clinical practice for preschool wheeze. However, there should be evidence of their effectiveness, empathetic communication between parents and HCPs and tests’ cost-effectiveness to support NHS funding.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/archdischild-2025-329433

Authors

More by this author
Role:
Author
ORCID:
0000-0002-5017-8347
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
https://ror.org/04ect1284


Publisher:
BMJ Publishing Group
Journal:
Archives of Disease in Childhood More from this journal
Article number:
archdischild-2025-329433
Publication date:
2025-12-20
Acceptance date:
2025-11-27
DOI:
EISSN:
1468-2044
ISSN:
0003-9888


Language:
English
Keywords:
Pubs id:
2353868
UUID:
uuid_bc631967-6fb7-4734-bb0a-5025fc499ded
Local pid:
pubs:2353868
Source identifiers:
3585376
Deposit date:
2025-12-22
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP